Request Demo
Last update 10 Dec 2025
T320-ADC
Last update 10 Dec 2025
Overview
Basic Info
Drug Type Antibody drug conjugate (ADC) |
Synonyms T320, T320 ADC, T320ADC |
Target |
Action modulators |
Mechanism tissue factor modulators(Tissue factor modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
RegulationOrphan Drug (United States) |
Login to view timeline
Structure/Sequence
Boost your research with our ADC technology data.
login
or
Related
1
Clinical Trials associated with T320-ADCCTR20251284
一项评价T320（ADC药物）在晚期实体瘤患者中的安全性、耐受性、药代动力学、免疫原性和初步疗效的开放、多中心的I期研究
[Translation] An open-label, multicenter Phase I study evaluating the safety, tolerability, pharmacokinetics, immunogenicity, and preliminary efficacy of T320 (ADC drug) in patients with advanced solid tumors
100 Clinical Results associated with T320-ADC
Login to view more data
100 Translational Medicine associated with T320-ADC
Login to view more data
100 Patents (Medical) associated with T320-ADC
Login to view more data
100 Deals associated with T320-ADC
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Advanced Malignant Solid Neoplasm | Phase 1 | China | 07 Apr 2025 | |
| Lung Cancer | IND Application | China | 01 Feb 2025 | |
| Pancreatic Cancer | IND Application | China | 01 Feb 2025 | |
| Uterine Cervical Cancer | IND Application | China | 01 Feb 2025 | |
| Non-Small Cell Lung Cancer | Preclinical | China | 03 Jun 2024 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Biosimilar
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free